Literature DB >> 6122212

Immunohistochemical localization of guanylate cyclase within neurons of rat brain.

M A Ariano, J A Lewicki, H J Brandwein, F Murad.   

Abstract

The immunohistochemical localization of guanylate cyclase [GTP pyrophosphate-lyase (cyclizing), EC 4.6.1.2] has been examined in rat neocortex, caudate-putamen, and cerebellum by using specific monoclonal antibodies. Immunofluorescence could be seen within somata and proximal dendrites of neurons in the these regions. A nuclear immunofluorescence reaction to guanylate cyclase was characteristically absent. The staining pattern for guanylate cyclase was coincident with previously described localizations of cyclic GMP immunofluorescence within medium spiny neurons of the caudate-putamen and pyramidal cells of the neocortex. Cerebellar guanylate cyclase immunoreactivity was primarily confined to Purkinje cells and their primary dendrites, similar to the pattern reported for cyclic GMP-dependent protein kinase localization. Guanylate cyclase immunofluorescence was abolished when the monoclonal antibodies were exposed to purified enzyme prior to incubation of the tissue slices or when control antibody was substituted for the primary antibody. Immunohistochemical localization of cyclic AMP in these same tissues was readily distinguished from that of guanylate cyclase or cyclic GMP, showing uniform fluorescence throughout the cell bodies of neurons and glial elements.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6122212      PMCID: PMC345954          DOI: 10.1073/pnas.79.4.1316

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  Biochemical characterization of postsynaptically localized cyclic nucleotide phosphodiesterase.

Authors:  M A Ariano; M M Appleman
Journal:  Brain Res       Date:  1979-11-16       Impact factor: 3.252

2.  Characterization of immunofluorescent cyclic GMP-positive fibres in the central nervous system.

Authors:  R Cumming; G Arbuthnott; A Steiner
Journal:  J Cyclic Nucleotide Res       Date:  1979-12

3.  Cyclic nucleotide and protein kinase immunocytochemistry.

Authors:  W A Spruill; A L Steiner
Journal:  Adv Cyclic Nucleotide Res       Date:  1979

4.  Immunohistochemical localization of cyclic GMP-dependent protein kinase in mammalian brain.

Authors:  S M Lohmann; U Walter; P E Miller; P Greengard; P De Camilli
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

5.  Immunocytochemical localization of cyclic GMP: light and electron microscope evidence for involvement of neuroglia.

Authors:  V Chan-Palay; S L Palay
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

6.  Production and characterization of monoclonal antibodies to soluble rat lung guanylate cyclase.

Authors:  H Brandwein; J Lewicki; F Murad
Journal:  Proc Natl Acad Sci U S A       Date:  1981-07       Impact factor: 11.205

7.  Purified guanylate cyclase: characterization, iodination and preparation of monoclonal antibodies.

Authors:  J A Lewicki; H J Brandwein; S A Waldman; F Murad
Journal:  J Cyclic Nucleotide Res       Date:  1980

8.  Relationships between seizure activity and cyclic nucleotide levels in brain.

Authors:  J A Ferrendelli; A C Blank; R A Gross
Journal:  Brain Res       Date:  1980-10-27       Impact factor: 3.252

9.  Localization of cyclic GMP-dependent protein kinase and substrate in mammalian cerebellum.

Authors:  D J Schlichter; J A Detre; D W Aswad; B Chehrazi; P Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

10.  The effects of kainic acid injections on guanylate cyclase activity in the rat caudatoputamen, nucleus accumbens and septum.

Authors:  I Walaas
Journal:  J Neurochem       Date:  1981-01       Impact factor: 5.372

View more
  22 in total

Review 1.  Regulation of AMPA receptors by phosphorylation.

Authors:  A L Carvalho; C B Duarte; A P Carvalho
Journal:  Neurochem Res       Date:  2000-10       Impact factor: 3.996

2.  Exploration of signal transduction pathways in cerebellar long-term depression by kinetic simulation.

Authors:  S Kuroda; N Schweighofer; M Kawato
Journal:  J Neurosci       Date:  2001-08-01       Impact factor: 6.167

3.  Persistent changes in spontaneous firing of Purkinje neurons triggered by the nitric oxide signaling cascade.

Authors:  Spencer L Smith; Thomas S Otis
Journal:  J Neurosci       Date:  2003-01-15       Impact factor: 6.167

Review 4.  Parallel fiber plasticity.

Authors:  Nicholas A Hartell
Journal:  Cerebellum       Date:  2002 Jan-Mar       Impact factor: 3.847

5.  Layer-specific NO dependence of long-term potentiation and biased NO release in layer V in the rat auditory cortex.

Authors:  H Wakatsuki; H Gomi; M Kudoh; S Kimura; K Takahashi; M Takeda; K Shibuki
Journal:  J Physiol       Date:  1998-11-15       Impact factor: 5.182

Review 6.  Role of nitric oxide on motor behavior.

Authors:  E A Del Bel; F S Guimarães; M Bermúdez-Echeverry; M Z Gomes; A Schiaveto-de-souza; F E Padovan-Neto; V Tumas; A P Barion-Cavalcanti; M Lazzarini; L P Nucci-da-Silva; D de Paula-Souza
Journal:  Cell Mol Neurobiol       Date:  2005-03       Impact factor: 5.046

Review 7.  Histochemistry of nucleotidyl cyclases and cyclic nucleotide phosphodiesterases.

Authors:  G Poeggel; H Luppa
Journal:  Histochem J       Date:  1988-05

8.  Inhibition of cGMP breakdown promotes the induction of cerebellar long-term depression.

Authors:  N A Hartell
Journal:  J Neurosci       Date:  1996-05-01       Impact factor: 6.167

9.  Nitric oxide is required for the induction and heterosynaptic spread of long-term potentiation in rat cerebellar slices.

Authors:  S Jacoby; R E Sims; N A Hartell
Journal:  J Physiol       Date:  2001-09-15       Impact factor: 5.182

10.  Nitric oxide-soluble guanylyl cyclase signaling regulates corticostriatal transmission and short-term synaptic plasticity of striatal projection neurons recorded in vivo.

Authors:  Stephen Sammut; Sarah Threlfell; Anthony R West
Journal:  Neuropharmacology       Date:  2009-12-05       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.